Cresco Labs Files 6-K for Q4 2023 Results
Ticker: CRLBF · Form: 6-K · Filed: Mar 13, 2024 · CIK: 1832928
| Field | Detail |
|---|---|
| Company | Cresco Labs Inc. (CRLBF) |
| Form Type | 6-K |
| Filed Date | Mar 13, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-results, 6-K
TL;DR
Cresco Labs dropped Q4 2023 earnings, check the 6-K for deets.
AI Summary
Cresco Labs Inc. filed a Form 6-K on March 13, 2024, to report its fourth quarter and full year 2023 results. The filing includes a news release detailing these financial outcomes. Charles Bachtell, CEO, signed the report.
Why It Matters
This filing provides investors with the latest financial performance data for Cresco Labs, crucial for understanding the company's current health and future prospects in the cannabis industry.
Risk Assessment
Risk Level: medium — The cannabis industry is subject to significant regulatory and market volatility, impacting companies like Cresco Labs.
Key Players & Entities
- Cresco Labs Inc. (company) — Registrant
- Charles Bachtell (person) — Chief Executive Officer
- March 13, 2024 (date) — Filing date and news release date
- 2023 (date) — Reporting period for financial results
FAQ
What specific financial results are detailed in the news release attached to this 6-K?
The filing indicates that Exhibit 99.1 is a news release dated March 13, 2024, reporting Cresco Labs' fourth quarter and full year 2023 results. Specific figures would be found within that exhibit.
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed by Cresco Labs Inc. for the month of March 2024, primarily to furnish a news release containing its Q4 and full year 2023 financial results.
Who signed the Form 6-K on behalf of Cresco Labs Inc.?
Charles Bachtell, the Chief Executive Officer of Cresco Labs Inc., signed the report on March 13, 2024.
Which SEC form does Cresco Labs indicate it will file its annual reports under?
Cresco Labs Inc. indicates it will file its annual reports under Form 40-F.
What is Cresco Labs Inc.'s principal executive office address?
Cresco Labs Inc.'s principal executive offices are located at 400 W Erie St Suite 110, Chicago, IL 60654.
Filing Stats: 149 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2024-03-13 09:41:34
Filing Documents
- q42023form6-k.htm (6-K) — 11KB
- q42023pressrelease.htm (EX-99.1) — 241KB
- 0001832928-24-000019.txt ( ) — 254KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CRESCO LABS INC. Date March 13, 2024 By s Charles Bachtell Charles Bachtell Chief Executive Officer